MA
DMTX

MUFG Americas’s Dimension Therapeutics, Inc DMTX Stock Holding History

MUFG Americas’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-215
Closed – – 1271
2017
Q1 		$0 Hold
215
– – ﹤0.01% 1234
2016
Q4 		$1K Sell
215
-225
-51% -$1.2K ﹤0.01% 1088
2016
Q3 		$4K Sell
440
-220
-33% -$1.59K ﹤0.01% 1023
2016
Q2 		$4K Buy
+660
New +$5.03K ﹤0.01% 1058

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

MUFG Americas's DMTX Position: Q2 2017 in Review

MUFG Americas sold out of Dimension Therapeutics, Inc (DMTX) in Q2 2017, closing a stake of 215 shares.

MUFG Americas first reported a position in DMTX in Q2 2016 and held it in 4 quarters. The position peaked at $4K in Q3 2016. 35 funds tracked by Wall St. Rank hold DMTX as of Q2 2017.

  • MUFG Americas reported no remaining Dimension Therapeutics, Inc position as of Q2 2017 after selling out during the quarter.
  • MUFG Americas sold 215 Dimension Therapeutics, Inc shares in Q2 2017.
  • MUFG Americas first reported a position in Dimension Therapeutics, Inc in Q2 2016 and held it in 4 quarters.
  • MUFG Americas's Dimension Therapeutics, Inc position peaked at $4K in Q3 2016.
  • 35 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q2 2017.

Based on MUFG Americas's 13F filing for Q2 2017, filed 7 Aug 2017.